94 related articles for article (PubMed ID: 35401923)
21. Roles of the Dynamic Tumor Immune Microenvironment in the Individualized Treatment of Advanced Clear Cell Renal Cell Carcinoma.
Lin E; Liu X; Liu Y; Zhang Z; Xie L; Tian K; Liu J; Yu Y
Front Immunol; 2021; 12():653358. PubMed ID: 33746989
[TBL] [Abstract][Full Text] [Related]
22. Identification and Utilization of Biomarkers to Predict Response to Immune Checkpoint Inhibitors.
Gjoerup O; Brown CA; Ross JS; Huang RSP; Schrock A; Creeden J; Fabrizio D; Tolba K
AAPS J; 2020 Oct; 22(6):132. PubMed ID: 33057937
[TBL] [Abstract][Full Text] [Related]
23. CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types.
Jiang A; Zhou Y; Gong W; Pan X; Gan X; Wu Z; Liu B; Qu L; Wang L
Oxid Med Cell Longev; 2022; 2022():5910575. PubMed ID: 35401923
[TBL] [Abstract][Full Text] [Related]
24. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
[TBL] [Abstract][Full Text] [Related]
25. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
26. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
Dong X; Gu DN; Wang O; Ye Z
Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
[TBL] [Abstract][Full Text] [Related]
27. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
28. Elevated SNRPA1, as a Promising Predictor Reflecting Severe Clinical Outcome
Jiang A; Meng J; Gong W; Zhang Z; Gan X; Wang J; Wu Z; Liu B; Qu L; Wang L
Front Immunol; 2022; 13():842069. PubMed ID: 35281041
[TBL] [Abstract][Full Text] [Related]
29. A Hypoxia Signature for Predicting Prognosis and Tumor Immune Microenvironment in Adrenocortical Carcinoma.
Chen X; Yan L; Lu Y; Jiang F; Zeng N; Yang S; Ma X
J Oncol; 2021; 2021():2298973. PubMed ID: 34603443
[TBL] [Abstract][Full Text] [Related]
30. Integrated Profiling Identifies CCNA2 as a Potential Biomarker of Immunotherapy in Breast Cancer.
Wang Y; Zhong Q; Li Z; Lin Z; Chen H; Wang P
Onco Targets Ther; 2021; 14():2433-2448. PubMed ID: 33859479
[TBL] [Abstract][Full Text] [Related]
31. Roundabout homolog 1 inhibits proliferation via the YY1-ROBO1-CCNA2-CDK2 axis in human pancreatic cancer.
Chen Q; Shen P; Ge WL; Yang TY; Wang WJ; Meng LD; Huang XM; Zhang YH; Cao SJ; Miao Y; Jiang KR; Zhang JJ
Oncogene; 2021 Apr; 40(15):2772-2784. PubMed ID: 33714986
[TBL] [Abstract][Full Text] [Related]
32. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
33. PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer.
Rizzo A; Ricci AD; Brandi G
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33535621
[TBL] [Abstract][Full Text] [Related]
34. Cancer Statistics, 2021.
Siegel RL; Miller KD; Fuchs HE; Jemal A
CA Cancer J Clin; 2021 Jan; 71(1):7-33. PubMed ID: 33433946
[TBL] [Abstract][Full Text] [Related]
35. CellMiner Cross-Database (CellMinerCDB) version 1.2: Exploration of patient-derived cancer cell line pharmacogenomics.
Luna A; Elloumi F; Varma S; Wang Y; Rajapakse VN; Aladjem MI; Robert J; Sander C; Pommier Y; Reinhold WC
Nucleic Acids Res; 2021 Jan; 49(D1):D1083-D1093. PubMed ID: 33196823
[TBL] [Abstract][Full Text] [Related]
36. Identifying Common Genes Related to Platelet and Immunity for Lung Adenocarcinoma Prognosis Prediction.
Zhou C; Wang Y; Lei L; Ji MH; Yang JJ; Xia H
Front Mol Biosci; 2020; 7():563142. PubMed ID: 33195410
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
